Overview

Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether the new inactivated polio vaccine that is based on attenuated poliovirus strains is safe and to evaluate the immune response in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Pauline Verdijk
Collaborator:
World Health Organization
Treatments:
Vaccines